KIMBERLY BELLON: Open Payments
NPI 1144850462 · EUNICE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$230 in 14 payments from 9 companies in 2025. Trend: 2023 $186 · 2024 $252 · 2025 $230
Food & beverage: $230
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $30 |
| ABBVIE INC. | 2 | $29 |
| Lilly USA, LLC | 2 | $28 |
| Ethicon US, LLC | 1 | $23 |
| Novo Nordisk Inc | 1 | $18 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
| Lundbeck LLC | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
Products named: BREZTRI, CAPLYTA, VRAYLAR, SURGIFLO Hemostatic Matrix, FANAPT, REXULTI, Kerendia, MOUNJARO.
Industry payments across LA — which companies pay providers there.
